About us
Investor Relations
Fact Sheet
Products & Services
Support
Animal Welfare
Events
Career
Visit our main locations

Canada / Denmark / Hungary
 Events
Pharmaceutical Toxicology Course, PERI, Arlington, VA
 

REACH, Biocidal Products Directive, Agchemforum & Environmental Risk Assessments for Human & Veterinary Medicines 2008
 

Subscribe to our Mailing list!
 Customer service
1-888-353-2240    

Fact Sheet 

 

Q3 2007 Highlights

    • Record revenue of $14.1 million
    • Net earnings of $1.0 million
    • Earnings per share of $0.06
    • Expansion: Phase I completed for all sites.  Phase II to be completed by Q4 2008 in Canada and early 2010 in Denmark.

 

Investor Information

  • TSX Symbol: LRI
  • Shares Outstanding: 18M
  • Fully Diluted: 19.3M
  • Market Cap. August 21, 07: $139M
  • Year-end: December 31st

Ownership

  • Management: 1%
  • Institutions: ≈ 85-89%
  • Retail: ≈ 10 -14%

 

Management Team

  • Luc Mainville, President and CEO
  • Louise Bussières, Vice-President, Finance
  • Andy Makin, Managing Director, Denmark
  • Christopher Banks, Managing Director, Hungary
  • Denis Pilon, Chief Operating Officer, Canada

Nine-Monthf 2007 Highlights

  • $42.4 million revenue
  • $3.9 million net earnings
  • $0.22 earnings per share
 Stock quotes

 News  LAB Research News archives
LAB Research Announces its 2008 First Quarter Financial Results
 

LAB Research Inc to hold Annual Shareholder Meeting May 12, 2008
 

 Investor relations
Dominic Sicotte
1.866.633.9551, ext. 101
dsicotte@echoesfinancial.com
     
Français | Home | About | Investor Relations | Careers | Corporate Profile | Products | Animal Welfare | Events | Customers Services
Copyright © 2006 LAB Research Inc. All Rights Reserved | Data Privacy Policy